Tag: catheter-directed thrombolysis
Surmodics receives FDA 510(k) clearance for Pounce XL thrombectomy system
Surmodics has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for its Pounce XL thrombectomy system.
The Pounce XL thrombectomy...
Thrombolex announces new insights from the RESCUE trial with the Bashir...
Thrombolex has announced never-before-reported major reductions in obstruction in all of the segmental pulmonary arteries (PA), based on independent core lab data analysis of...
SIR deems endovascular management acceptable treatment option for certain iliofemoral DVT...
The Society of Interventional Radiology (SIR) published a position statement deeming endovascular thrombus removal “an acceptable treatment option in selected patients with acute iliofemoral...
SUNSET sPE thrombolysis trial completes enrolment phase
The “Standard versus ultrasound-assisted catheter thrombolysis for submassive pulmonary embolism” (SUNSET sPE) trial, a randomised, single-blinded clinical trial comparing ultrasound-assisted thrombolysis (USAT) to standard...
ATTRACT analysis finds improved quality of life for iliofemoral DVT patients...
An analysis of data from the ATTRACT trial, published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVSVL), has revealed that quality...
Successful thrombolysis significantly influences clinical scores and QoL but not shown...
Additional ultrasound-accelerated catheter-directed thrombolysis does not lower the risk of post-thrombotic syndrome in patients with acute iliofemoral deep-vein thrombosis (DVT), according to findings of...
ATTRACT fails to meet primary endpoint, but experts agree results are...
Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of...
